HomeTARA • NASDAQ
add
Protara Therapeutics Inc
Previous close
$2.60
Day range
$2.60 - $3.00
Year range
$1.20 - $5.24
Market cap
55.75M USD
Avg Volume
191.86K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.33M | 15.23% |
Net income | -11.22M | -13.78% |
Net profit margin | — | — |
Earnings per share | -0.50 | 42.53% |
EBITDA | -12.25M | -15.30% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 81.50M | 10.08% |
Total assets | 94.09M | 6.36% |
Total liabilities | 12.30M | 6.85% |
Total equity | 81.79M | — |
Shares outstanding | 20.63M | — |
Price to book | 0.66 | — |
Return on assets | -31.50% | — |
Return on capital | -33.59% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -11.22M | -13.78% |
Cash from operations | -8.43M | -28.55% |
Cash from investing | -29.39M | -560.80% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -37.82M | -17,911.43% |
Free cash flow | -4.70M | -44.75% |
About
Founded
2006
Website
Employees
27
